Don’t reinvent the wheel — adapt it. Locate before you correct, because where a failure appears isn’t necessarily where it gets fixed.
- Why CMC Must Shape Critical Decisions Early In Development
- Closing The Gap Between Modeling And GMP Predictive Control
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- IT/OT Convergence Could Lighten Biopharma's Automation Burden
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
- Want More Sustainable Biopharma Packaging? Try These Levers
- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
EDITOR'S DESK
-
Contextualizing Data To Enable AI And Prevent Knowledge Leaks
Bioprocess Online's Tyler Menichiello interviews Martin Kockx, a principal manufacturing systems engineer at Vertex Pharmaceuticals, on his presentation at 2026 BPI, “Transforming Biomanufacturing: Why Architecture Must Precede Analytics."
An interview with Jacqualyn Schulman, Ph.D., a principal scientist at Bristol Myers Squibb (BMS), on her presentation at BPI 2026, “Fast-Tracking CHO Cell Line Development Using Integrated Engineering Strategies.”
This article captures key takeaways from a BioProcess International keynote by Preeya Boppana, director of MSAT process analytics and laboratories at AstraZeneca, titled “Transforming Biologics Manufacturing: Leveraging Predictive Analytics and Advanced Process Control for Next-Generation Operations.”
Regulatory compliance and cGMP manufacturing expert Tatyana Matveeva, Ph.D., explains the role and importance of a quality unit in an organization, as well as what happens when it’s compromised.
Experts discuss where productivity gains can be achieved and how development teams should seek to improve process performance in this recap of the Bioprocess Online Live event "The Levers And Tradeoffs That Drive Process Productivity."
GUEST COLUMNISTS
-
Developing Your Vapor Phase Hydrogen Peroxide Cycle
Vapor phase hydrogen peroxide has been used for decades as a surface decontaminant in pharma/biotech, but there has been little guidance on how to establish the parameters. Here's an industry consensus from BioPhorum.
-
Closing The Gap Between Modeling And GMP Predictive Control
Predictive control offers opportunities to improve process consistency, reduce variability, and respond to changing manufacturing conditions before they cause deviations.
-
IT/OT Convergence Could Lighten Biopharma's Automation Burden
Integration lets frameworks talk to each other through middleware. Convergence brings them under the same architecture, which can can reduce costs and maintenance.
-
Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
Determining whether a drug manufacturing environment is stable, drifting, or developing a recurring loss-of-control signal requires integrated trend evaluation.
-
Want More Sustainable Biopharma Packaging? Try These Levers
Biopharmaceutical packaging optimization must not compromise the goods inside or compliance, so sustainable packaging developers might need to think outside the box.
-
What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
The European Commission and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) consulted on draft Annex 22, Artificial Intelligence. Here's what you should know.
-
How To Keep Your 'Big Bang' Platform Switch From Becoming A Big Bust
Leaders at a Roche fill/finish facility describe the tactile steps involve to change EMS, ERP, and WMS all at once with no rollback option.
-
How Is Your Glass Supplier Adapting To Europe's Energy Crisis?
Europe's glass manufacturers, including those making pharmaceutical lab glassware, have experienced a series of energy shocks. Many have adopted sustainability practices.
BIOPROCESSING WHITE PAPERS
-
Single-Use Technology And Environmental Responsibility In Biopharmaceuticals
Learn about strategies such as regional manufacturing and advanced single-use systems and their potential to minimize carbon footprint and enhance sustainable biomanufacturing.
-
Perfusion Cell Line Development For Intensified Processes5/5/2025
The biopharmaceutical industry is transforming by shifting to continuous and intensified upstream bioprocesses, which are driven by evolving demands. Discover the key goals and innovations shaping this transition for modern healthcare.
-
Optimizing mAb Production: Upstream Process Intensification Strategies9/1/2026
See how integrated upstream and downstream intensification strategies can increase monoclonal antibody yield, streamline workflows, improve facility utilization, and reduce manufacturing costs.
-
Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy2/6/2026
The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.
-
Beyond The Label: Solving Traceability Challenges In Bioproduction9/21/2026
Standardizing raw material traceability and lot verification reduces variability, protecting bioprocess consistency and regulatory compliance.
-
Leveraging 3 Distinct Resins To Provide Effective Impurity Removal For mAbs And Novel Antibody Derivatives11/3/2025
Due to the complexity of bispecifics, Fc-fusion proteins, and Fab fragments, their manufacturing poses added purification challenges and requires a robust toolkit of purification techniques.
BIOPROCESSING APP NOTES & CASE STUDIES
- Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS
- Flow Cytometric Analysis: Differentiation Potential Of Human Stem Cells
- Is Your Nanopositioner Quantum Ready?
- Prefilters For Protecting Medical Water Quality
- Metabolic Rate Monitoring Of Undifferentiated iPS Cells And Expression Analysis Of Differentiation Markers
- The Real Value Of Continuous Bioprocessing Is In Connected Unit Operations
- On The Ground At BPI: Where AI Dreams Meet Operational Reality
- On The Ground At BPI: Tatyana Matveeva, Ph.D., On Distributed Manufacturing Models
- Contextualizing Data To Enable AI And Prevent Knowledge Leaks
- On The Ground At BPI: Jacqualyn Schulman, Ph.D., On Accelerating Clonal CLD
- AstraZeneca's Focus On Predictive Control, Semi-Autonomous Processing
- Prioritizing Quality Over Everything
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Editorial Collections are subscriber-only, curated resources that combine expert interviews, feature articles, and industry analysis to help readers better understand emerging trends, operational challenges, regulatory developments, and best practices shaping the biopharma industry.
More Editorial CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
- Planning For Scale From The Start: Where Early Development Decisions Create Commercial Risk
- Intensifying CHO Fed-Batch With N-1 Perfusion: 14 To 10 Days
- The Critical Role Of Integrated Handling Design
- Decoding Biologic Performance: Combining SPR And Cell-Based Assays To Drive Development Decisions
- Rethinking Facility Design For The Reality Of Complex Biologics
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 11.16.26 -- Rethinking The Inputs Behind Scalable T-Cell Therapy
- 11.16.26 -- What If The Body Could Make Its Own Medicine?
- 11.16.26 -- Overlooked Aspects Of Cell Line Development
- 11.14.26 -- Bioprocess Online Newsletter - Best of October
- 11.13.26 -- Streamlining Clonal Cell Line Selection With Susan Sharfstein, Ph.D.

